Deferasirox treatment for up to 3 years in iron-overloaded pediatric patients reduces serum ferritin with a manageable safety profile

Abstract

54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 08-11, 2012 -- Atlanta, GAWOS: 000314049602043Amer Soc Hematol (ASH

    Similar works